IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
Novo Nordisk A/S
Paul M Ridker; Matt Devalaraja; Florian M M Baeres; Mads D M Engelmann; G Kees Hovingh; Milana Ivkovic; Larry Lo; Douglas Kling; Pablo Pergola; Dominic Raj; Peter Libby; Michael Davidson; RESCUE Investigators